<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The management of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> represents a key component of clinical practice for members of the British Society of Gastroenterology (BSG) </plain></SENT>
<SENT sid="1" pm="."><plain>There has been considerable progress in management strategies affecting <z:hpo ids='HP_0000001'>all</z:hpo> aspects of clinical care since the publication of previous BSG guidelines in 2004, necessitating the present revision </plain></SENT>
<SENT sid="2" pm="."><plain>Key components of the present document worthy of attention as having been subject to re-assessment, and revision, and having direct impact on practice include: The data generated by the nationwide audits of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) management in the UK in 2006, and 2008 </plain></SENT>
<SENT sid="3" pm="."><plain>The publication of 'Quality Care: service standards for the healthcare of people with IBD' in 2009 </plain></SENT>
<SENT sid="4" pm="."><plain>The introduction of the Montreal classification for <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The revision of recommendations for the use of immunosuppressive therapy </plain></SENT>
<SENT sid="6" pm="."><plain>The detailed analysis, guidelines and recommendations for the safe and appropriate use of biological therapies in <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The reassessment of the role of surgery in disease management, with emphasis on the importance of multi-disciplinary decision-making in complex cases </plain></SENT>
<SENT sid="8" pm="."><plain>The availablity of new data on the role of reconstructive surgery in <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>The cross-referencing to revised guidelines for colonoscopic surveillance, for the management of <z:e sem="disease" ids="C0005944" disease_type="Disease or Syndrome" abbrv="">metabolic bone disease</z:e>, and for the care of children with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Use of the BSG discussion forum available on the BSG website to enable ongoing feedback on the published document http://www.bsg.org.uk/forum (accessed Oct 2010) </plain></SENT>
<SENT sid="11" pm="."><plain>The present document is intended primarily for the use of clinicians in the United Kingdom, and serves to replace the previous BSG guidelines in IBD, while complementing recent consensus statements published by the European Crohn's and <z:hpo ids='HP_0002583'>Colitis</z:hpo> Organisation (ECCO) https://www.ecco-ibd.eu/index.php (accessed Oct 2010) </plain></SENT>
</text></document>